EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study

Background and Aims: Portal hypertension is a serious adverse event of liver cirrhosis. Recently, we developed a simple novel technique for EUS-guided portal pressure gradient (PPG) measurement (PPGM). Our animal studies showed excellent correlation between EUS-PPGM and interventional radiology-acqu...

Full description

Bibliographic Details
Main Authors: Jason B. Samarasena, MD, Jason Y. Huang, FRACP, Takeshi Tsujino, MD, PhD, Daniel Thieu, BSc, Allen Yu, BSc, Ke-Qin Hu, MD, John Lee, MD, Kenneth J. Chang, MD
Format: Article
Language:English
Published: Elsevier 2018-11-01
Series:VideoGIE
Online Access:http://www.sciencedirect.com/science/article/pii/S2468448118301395
_version_ 1827877630246912000
author Jason B. Samarasena, MD
Jason Y. Huang, FRACP
Takeshi Tsujino, MD, PhD
Daniel Thieu, BSc
Allen Yu, BSc
Ke-Qin Hu, MD
John Lee, MD
Kenneth J. Chang, MD
author_facet Jason B. Samarasena, MD
Jason Y. Huang, FRACP
Takeshi Tsujino, MD, PhD
Daniel Thieu, BSc
Allen Yu, BSc
Ke-Qin Hu, MD
John Lee, MD
Kenneth J. Chang, MD
author_sort Jason B. Samarasena, MD
collection DOAJ
description Background and Aims: Portal hypertension is a serious adverse event of liver cirrhosis. Recently, we developed a simple novel technique for EUS-guided portal pressure gradient (PPG) measurement (PPGM). Our animal studies showed excellent correlation between EUS-PPGM and interventional radiology-acquired PPGM. In this video we demonstrate the results of the first human pilot study of EUS-PPGM in patients with liver disease. Methods: EUS-PPGM was performed by experienced endosonographers using a linear echoendoscope, a 25-gauge FNA needle, and a novel compact manometer. The portal vein and hepatic vein (or inferior vena cava) were targeted by use of a transgastric or transduodenal approach. Feasibility was defined as successful PPGM in each patient. Safety was based on adverse events captured in a postprocedural interview. Results: Twenty-eight patients underwent EUS-PPGM with 100% technical success and no adverse events. PPG ranged from 1.5 to 19 mm Hg and had excellent correlation with clinical parameters of portal hypertension, including the presence of varices (P = .0002), PH gastropathy (P = .007), and thrombocytopenia (P = .036). Conclusion: This novel technique of EUS-PPGM using a 25-gauge needle and compact manometer is feasible and appears safe. Given the availability of EUS and the simplicity of the manometry setup, EUS-guided PPG may represent a promising breakthrough for procuring indispensable information in the management of patients with liver disease.
first_indexed 2024-03-12T17:40:18Z
format Article
id doaj.art-0579d4f8c8a84738b881ac6c01a5792c
institution Directory Open Access Journal
issn 2468-4481
language English
last_indexed 2024-03-12T17:40:18Z
publishDate 2018-11-01
publisher Elsevier
record_format Article
series VideoGIE
spelling doaj.art-0579d4f8c8a84738b881ac6c01a5792c2023-08-04T05:49:04ZengElsevierVideoGIE2468-44812018-11-01311361363EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot studyJason B. Samarasena, MD0Jason Y. Huang, FRACP1Takeshi Tsujino, MD, PhD2Daniel Thieu, BSc3Allen Yu, BSc4Ke-Qin Hu, MD5John Lee, MD6Kenneth J. Chang, MD7H. H. Chao Comprehensive Digestive Disease Center, Division of Gastroenterology and Hepatology, University of California, Irvine, Orange, California, USAH. H. Chao Comprehensive Digestive Disease Center, Division of Gastroenterology and Hepatology, University of California, Irvine, Orange, California, USAH. H. Chao Comprehensive Digestive Disease Center, Division of Gastroenterology and Hepatology, University of California, Irvine, Orange, California, USAH. H. Chao Comprehensive Digestive Disease Center, Division of Gastroenterology and Hepatology, University of California, Irvine, Orange, California, USAH. H. Chao Comprehensive Digestive Disease Center, Division of Gastroenterology and Hepatology, University of California, Irvine, Orange, California, USAH. H. Chao Comprehensive Digestive Disease Center, Division of Gastroenterology and Hepatology, University of California, Irvine, Orange, California, USAH. H. Chao Comprehensive Digestive Disease Center, Division of Gastroenterology and Hepatology, University of California, Irvine, Orange, California, USAH. H. Chao Comprehensive Digestive Disease Center, Division of Gastroenterology and Hepatology, University of California, Irvine, Orange, California, USABackground and Aims: Portal hypertension is a serious adverse event of liver cirrhosis. Recently, we developed a simple novel technique for EUS-guided portal pressure gradient (PPG) measurement (PPGM). Our animal studies showed excellent correlation between EUS-PPGM and interventional radiology-acquired PPGM. In this video we demonstrate the results of the first human pilot study of EUS-PPGM in patients with liver disease. Methods: EUS-PPGM was performed by experienced endosonographers using a linear echoendoscope, a 25-gauge FNA needle, and a novel compact manometer. The portal vein and hepatic vein (or inferior vena cava) were targeted by use of a transgastric or transduodenal approach. Feasibility was defined as successful PPGM in each patient. Safety was based on adverse events captured in a postprocedural interview. Results: Twenty-eight patients underwent EUS-PPGM with 100% technical success and no adverse events. PPG ranged from 1.5 to 19 mm Hg and had excellent correlation with clinical parameters of portal hypertension, including the presence of varices (P = .0002), PH gastropathy (P = .007), and thrombocytopenia (P = .036). Conclusion: This novel technique of EUS-PPGM using a 25-gauge needle and compact manometer is feasible and appears safe. Given the availability of EUS and the simplicity of the manometry setup, EUS-guided PPG may represent a promising breakthrough for procuring indispensable information in the management of patients with liver disease.http://www.sciencedirect.com/science/article/pii/S2468448118301395
spellingShingle Jason B. Samarasena, MD
Jason Y. Huang, FRACP
Takeshi Tsujino, MD, PhD
Daniel Thieu, BSc
Allen Yu, BSc
Ke-Qin Hu, MD
John Lee, MD
Kenneth J. Chang, MD
EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study
VideoGIE
title EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study
title_full EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study
title_fullStr EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study
title_full_unstemmed EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study
title_short EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study
title_sort eus guided portal pressure gradient measurement with a simple novel device a human pilot study
url http://www.sciencedirect.com/science/article/pii/S2468448118301395
work_keys_str_mv AT jasonbsamarasenamd eusguidedportalpressuregradientmeasurementwithasimplenoveldeviceahumanpilotstudy
AT jasonyhuangfracp eusguidedportalpressuregradientmeasurementwithasimplenoveldeviceahumanpilotstudy
AT takeshitsujinomdphd eusguidedportalpressuregradientmeasurementwithasimplenoveldeviceahumanpilotstudy
AT danielthieubsc eusguidedportalpressuregradientmeasurementwithasimplenoveldeviceahumanpilotstudy
AT allenyubsc eusguidedportalpressuregradientmeasurementwithasimplenoveldeviceahumanpilotstudy
AT keqinhumd eusguidedportalpressuregradientmeasurementwithasimplenoveldeviceahumanpilotstudy
AT johnleemd eusguidedportalpressuregradientmeasurementwithasimplenoveldeviceahumanpilotstudy
AT kennethjchangmd eusguidedportalpressuregradientmeasurementwithasimplenoveldeviceahumanpilotstudy